Pharmacodynamic effects of subinhibitory antibiotic concentrations (Q34118017)

31 July 2017

1 reference

title

Pharmacodynamic effects of subinhibitory antibiotic concentrations. (English)

1 reference

31 July 2017

1 reference

Odenholt I

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

International Journal of Antimicrobial Agents

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-8

1 reference

Dosage schedules of antimicrobial agents: a historical review.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Penicillin Therapy with Prolonged Interval Dosage Schedules

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

The Recovery Period following Exposure of Bacteria to Penicillins

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

An in vivo model for evaluation of the postantibiotic effect

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effect of antibiotic protein binding on the killing rate of Staphylococcus aureus and on the paradoxical phenomenon

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Morphological Effects of Penicillin on Bacteria

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Aberrant form of Pseudomonas aeruginosa in sputum and cerebrospinal fluid causing infection in a compromised patient

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

THE SPIROCHETICIDAL ACTION OF PENICILLIN IN VITRO AND ITS TEMPERATURE COEFFICIENT.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

PENICILLIN: ITS ANTIBACTERIAL EFFECT IN WHOLE BLOOD AND SERUM FOR THE HEMOLYTIC STREPTOCOCCUS AND STAPHYLOCOCCUS AUREUS

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Abnormal Forms of Bacteria Produced by Antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effects of Subminimal Inhibitory Concentrations of Antibiotics in Experimental Infections

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effects of ten milligrams of ampicillin per day on urinary tract infections

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Subinhibitory concenfrations of antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Antibiotics and Phagocytosis

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic effect of imipenem on Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

In vivo and in vitro study of several pharmacodynamic effects of meropenem

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Post-antibiotic effect of teicoplanin

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic Effect of Trovafloxacin against Gram-Positive and -Negative Organisms

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model

1 reference

https://api.crossref.org/works/10.1016/S0924-8579(00)00243-0

7 January 2021

10.1016/S0924-8579(00)00243-0

Identifiers

DOI

1 reference

31 July 2017

1 reference